By Mill Chart
Last update: Dec 4, 2023
Here's DOXIMITY INC-CLASS A (NYSE:DOCS) for you, a growth stock our stock screener believes is undervalued. NYSE:DOCS is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:DOCS has earned a 8 for growth:
ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NYSE:DOCS, the assigned 5 reflects its valuation:
To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:
Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.
For an up to date full fundamental analysis you can check the fundamental report of DOCS
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
DOXIMITY INC-CLASS A
NYSE:DOCS (2/22/2024, 11:15:46 AM)
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles.
This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors.
DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Investors seeking growth at a reasonable cost should explore DOXIMITY INC-CLASS A (NYSE:DOCS).
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
AI chatbots including ChatGPT and Bard believe these stocks are headed higher in the future, perhaps the near future.